Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic Disease
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Using a human pangenomic microarray, the researchers established expression profiles of nasal epithelial cells, collected by brushing of patients belonging to one of four distinct groups:
- allergic rhinitis to dust mite (AR) isolated (n=12),
- AR associated with bronchial hyperreactivity (n=12),
- AR associated with asthma (n=14),
- control (n=14).
| Condition | Intervention |
|---|---|
|
Allergic Rhinitis |
Procedure: Collection of nasal epithelial cells |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Screening |
| Official Title: | Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic |
- Transcriptome analysis: genes statistically modulated between groups, predictive biomarkers allowing correct classification of groups [ Time Frame: At the sample time ] [ Designated as safety issue: No ]
- Validation with other techniques: Q-PCR [ Time Frame: At the sample time ] [ Designated as safety issue: No ]
| Enrollment: | 80 |
| Study Start Date: | November 2004 |
| Study Completion Date: | October 2005 |
| Arms | Assigned Interventions |
|---|---|
|
A
Collection of nasal epithelial cells by brushing
|
Procedure: Collection of nasal epithelial cells
Collection of nasal epithelial cells by brushing
|
Detailed Description:
Context: Asthma is the most frequent chronic disease in childhood. Allergic rhinitis has been described as a risk factor to develop asthma. The objective of the study was to evaluate the contribution of the respiratory epithelium to development of allergic rhinitis and asthma and to identify the molecular mechanisms driving rhinitis toward asthma.
Methods: Using a human pangenomic microarray, we established expression profiles of nasal epithelial cells, collected by brushing of patients belonging to one of four distinct children 2 to 18 years of age groups:
- allergic rhinitis to dust mite (AR) isolated (n=12),
- AR associated with bronchial hyperreactivity (n=12),
- AR associated with asthma (n=14),
- control (n=14).
Eligibility| Ages Eligible for Study: | 6 Years to 17 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patients:
- Patients between 6 and 17 years old
- Patients with allergic rhinitis
Witness:
- Patients between 6 and 17 years old
- Patients without allergic rhinitis and asthma
Exclusion Criteria:
- Rhino-bronchitis infection dated from less than 15 days
- Patients younger than 6 or older than 17 years
Contacts and Locations| France | |
| Department of Pediatrics, Nice University Hospital | |
| Nice, France, 06000 | |
| Principal Investigator: | Marc Albertini, Professor | Department of Pediatrics of Nice University Hospital |
More Information
No publications provided by Centre Hospitalier Universitaire de Nice
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Département de la Recherche Clinique et de l'Innovation, CHU de Nice |
| ClinicalTrials.gov Identifier: | NCT00569361 History of Changes |
| Other Study ID Numbers: | CIR 2005 |
| Study First Received: | December 6, 2007 |
| Last Updated: | June 8, 2009 |
| Health Authority: | France: Direction Générale de la Santé France: Institutional Ethical Committee |
Keywords provided by Centre Hospitalier Universitaire de Nice:
|
allergic rhinitis to dust mite allergic rhinitis associated with bronchial hyperreactivity allergic rhinitis associated with asthma |
Additional relevant MeSH terms:
|
Rhinitis Nose Diseases Respiratory Tract Diseases Respiratory Tract Infections Otorhinolaryngologic Diseases |
ClinicalTrials.gov processed this record on May 23, 2013